NM_005422.4:c.2638A>G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_005422.4(TECTA):āc.2638A>Gā(p.Thr880Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000812 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TECTA | ENST00000392793.6 | c.2638A>G | p.Thr880Ala | missense_variant | Exon 10 of 24 | 5 | NM_005422.4 | ENSP00000376543.1 | ||
TECTA | ENST00000264037.2 | c.2638A>G | p.Thr880Ala | missense_variant | Exon 9 of 23 | 1 | ENSP00000264037.2 | |||
TECTA | ENST00000642222.1 | c.2638A>G | p.Thr880Ala | missense_variant | Exon 10 of 24 | ENSP00000493855.1 | ||||
TECTA | ENST00000645008.1 | c.-57A>G | upstream_gene_variant | ENSP00000496274.1 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251092Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135696
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461622Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727094
GnomAD4 genome AF: 0.000459 AC: 70AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74496
ClinVar
Submissions by phenotype
not provided Benign:2
- -
See Variant Classification Assertion Criteria. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Thr880Ala var iant in TECTA has not been previously reported in individuals with hearing loss, but has been identified in 0.23 % (24/10400) of African chromosomes by the Exom e Aggregation Consortium (ExAC, http://exac.broadinstitute.org; rs143315827). Co mputational prediction tools and conservation analysis do not provide strong sup port for or against an impact to the protein. In summary, while the clinical sig nificance of the p.Thr880Ala variant is uncertain, these data suggest it is more likely to be benign. -
Inborn genetic diseases Uncertain:1
The c.2638A>G (p.T880A) alteration is located in exon 9 (coding exon 9) of the TECTA gene. This alteration results from a A to G substitution at nucleotide position 2638, causing the threonine (T) at amino acid position 880 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at